- AU$639.03m
- AU$621.17m
- AU$143.84m
Brief: Jpmorgan Chase & Co Increases Voting Power In Polynovo To 6.30% - Filing
Australia's PolyNovo set to erase 8% losses it booked on ousting CEO
Morningstar does not foresee major changes in strategy, risk at PolyNovo under new CEO
PolyNovo slumps as CEO to leave in major update in 'bullying' saga
Australia's PolyNovo chief steps down after reports of rift with chair (updated)
Australia's PolyNovo CEO Swami Raote Steps Down
Brief: Polynovo Says CEO, Swami Raote, Will Cease His Employment
Australia's Polynovo recovers slightly from massive sell-off
Brief: Polynovo Ltd Responds To Media Article
Australia's Polynovo tumbles as it tries to oust CEO after report on 'bullying'
Brief: Polynovo Says Robyn Elliott Would Be Stepping Into Role As Acting CEO
Australia's Polynovo rises, Morningstar raises fair value estimate
Morningstar raises fair value estimate on Australia's Polynovo Ltd
Australia's PolyNovo eyes best day since July on record monthly sales
Brief: Polynovo Announces Sales Of $A10.1M For November
Brief: Polynovo Posts FY Net Income AUD 5.3 Mln
Australia's Polynovo extends gains on strong FY sales; Macquarie optimistic
Brief: Polynovo Posts FY24 Sales Of A$92 Mln
Aussie healthcare stocks set to log modest gains in first-half 2024